Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms.

Liao J, Schurr MJ, Sauer K.

J Bacteriol. 2013 Aug;195(15):3352-63. doi: 10.1128/JB.00318-13.

2.
3.

The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance.

Liao J, Sauer K.

J Bacteriol. 2012 Sep;194(18):4823-36. doi: 10.1128/JB.00765-12.

4.

The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ.

Chambers JR, Sauer K.

J Bacteriol. 2013 Oct;195(20):4678-88. doi: 10.1128/JB.00834-13.

5.

Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.

De Kievit TR, Parkins MD, Gillis RJ, Srikumar R, Ceri H, Poole K, Iglewski BH, Storey DG.

Antimicrob Agents Chemother. 2001 Jun;45(6):1761-70.

6.

Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa.

Maseda H, Yoneyama H, Nakae T.

Antimicrob Agents Chemother. 2000 Mar;44(3):658-64.

7.

Elevated levels of the second messenger c-di-GMP contribute to antimicrobial resistance of Pseudomonas aeruginosa.

Gupta K, Liao J, Petrova OE, Cherny KE, Sauer K.

Mol Microbiol. 2014 May;92(3):488-506. doi: 10.1111/mmi.12587.

8.

Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms.

Gillis RJ, White KG, Choi KH, Wagner VE, Schweizer HP, Iglewski BH.

Antimicrob Agents Chemother. 2005 Sep;49(9):3858-67.

10.

A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms.

Brooun A, Liu S, Lewis K.

Antimicrob Agents Chemother. 2000 Mar;44(3):640-6.

11.

BrlR from Pseudomonas aeruginosa is a c-di-GMP-responsive transcription factor.

Chambers JR, Liao J, Schurr MJ, Sauer K.

Mol Microbiol. 2014 May;92(3):471-87. doi: 10.1111/mmi.12562.

12.

Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.

Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM.

Arch Iran Med. 2015 Feb;18(2):102-8. doi: 015182/AIM.008.

13.
14.

Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.

Choudhury D, Das Talukdar A, Dutta Choudhury M, Maurya AP, Paul D, Dhar Chanda D, Chakravorty A, Bhattacharjee A.

PLoS One. 2015 Jul 29;10(7):e0133842. doi: 10.1371/journal.pone.0133842.

15.

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.

Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.

Diagn Microbiol Infect Dis. 2004 Sep;50(1):43-50.

PMID:
15380277
16.

Two routes of MexS-MexT-mediated regulation of MexEF-OprN and MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.

Uwate M, Ichise YK, Shirai A, Omasa T, Nakae T, Maseda H.

Microbiol Immunol. 2013 Apr;57(4):263-72. doi: 10.1111/1348-0421.12032.

17.
18.

Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.

Mulet X, Moyá B, Juan C, Macià MD, Pérez JL, Blázquez J, Oliver A.

Antimicrob Agents Chemother. 2011 Oct;55(10):4560-8. doi: 10.1128/AAC.00519-11.

19.

Simultaneous overexpression of multidrug efflux pumps in Pseudomonas aeruginosa non-cystic fibrosis clinical isolates.

Poonsuk K, Tribuddharat C, Chuanchuen R.

Can J Microbiol. 2014 Jul;60(7):437-43. doi: 10.1139/cjm-2014-0239.

PMID:
24909060
20.

Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin.

Llanes C, Köhler T, Patry I, Dehecq B, van Delden C, Plésiat P.

Antimicrob Agents Chemother. 2011 Dec;55(12):5676-84. doi: 10.1128/AAC.00101-11.

Items per page

Supplemental Content

Support Center